左炔诺孕酮宫内节育系统的非避孕用途。
Non-contraceptive applications of the levonorgestrel intrauterine system.
机构信息
Department of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco General Hospital and Bixby Center for Global Reproductive Health, University of California, San Francisco, CA, USA.
出版信息
Int J Womens Health. 2010 Aug 9;2:63-8. doi: 10.2147/ijwh.s6344.
Abstract
Intrauterine progestins have many important current and potential gynecologic applications. This article describes the evidence for use of intrauterine progestin for common gynecologic conditions beyond its important role in contraception. The pharmacology of and selection criteria for use of the levonorgestrel intrauterine device is discussed, and the evidence for use of intrauterine progestin delivery for menorrhagia, endometriosis management, uterine fibroids, adenomyosis and endometrial hyperplasia is reviewed.
摘要
宫内孕激素在妇科领域有许多重要的当前和潜在应用。本文介绍了除避孕作用外，宫内孕激素在常见妇科疾病中的应用证据。讨论了左炔诺孕酮宫内节育器的药理学和使用选择标准，并回顾了宫内孕激素用于月经过多、子宫内膜异位症管理、子宫肌瘤、子宫腺肌病和子宫内膜增生的证据。
相似文献
1
Non-contraceptive applications of the levonorgestrel intrauterine system.左炔诺孕酮宫内节育系统的非避孕用途。
Int J Womens Health. 2010 Aug 9;2:63-8. doi: 10.2147/ijwh.s6344.
2
Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications.宫内孕激素、孕激素拮抗剂和受体调节剂：妇科应用综述。
Am J Obstet Gynecol. 2010 May;202(5):420-8. doi: 10.1016/j.ajog.2009.10.863. Epub 2009 Dec 23.
3
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内节育系统的风险效益评估。
Drug Saf. 1996 Dec;15(6):430-40. doi: 10.2165/00002018-199615060-00006.
4
Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.使用左炔诺孕酮宫内节育系统对严重增大的子宫腺肌病子宫进行药物治疗。
Contraception. 1999 Sep;60(3):173-5. doi: 10.1016/s0010-7824(99)00075-x.
5
Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.使用左炔诺孕酮宫内节育器治疗子宫腺肌病相关月经过多。
Fertil Steril. 1997 Sep;68(3):426-9. doi: 10.1016/s0015-0282(97)00245-8.
6
Levonorgestrel-releasing intrauterine system: uses and controversies.左炔诺孕酮宫内节育系统：用途与争议
Expert Rev Med Devices. 2008 Jul;5(4):437-45. doi: 10.1586/17434440.5.4.437.
7
Laevonorgestrel intra-uterine system--a revolutionary intra-uterine device.左炔诺孕酮宫内节育系统——一种革命性的宫内节育器。
J Indian Med Assoc. 2007 Jul;105(7):380, 382-5.
8
Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.经皮雌激素联合左炔诺孕酮宫内节育器治疗更年期症状：临床及子宫内膜反应
Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):114-9. doi: 10.1016/0002-9378(95)90095-0.
9
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.左炔诺孕酮宫内节育器作为一种具有治疗特性的避孕方法。
Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2.
10
Hormonal intrauterine devices.激素宫内节育器
Ann Med. 1993 Apr;25(2):143-7. doi: 10.3109/07853899309164158.
引用本文的文献
1
Management of endometrial modifications in perimenopausal women.围绝经期女性子宫内膜改变的管理
Clujul Med. 2015;88(2):101-10. doi: 10.15386/cjmed-421. Epub 2015 Apr 15.
2
Morphological and Ultrastructural Changes in Human Endometrium Following Low-Dose Levonorgestrel Contraceptive Intrauterine Systems (LNG-IUS-12) 13.5 mg.低剂量左炔诺孕酮宫内节育系统（LNG-IUS-12，13.5毫克）作用后人类子宫内膜的形态学和超微结构变化
J Obstet Gynaecol India. 2015 Oct;65(5):323-7. doi: 10.1007/s13224-014-0620-6. Epub 2014 Oct 29.
3
Efficacy of levonorgestrel releasing intrauterine system for the treatment of menorrhagia due to benign uterine lesions in perimenopausal women.左炔诺孕酮宫内缓释系统治疗围绝经期妇女良性子宫病变所致月经过多的疗效
J Midlife Health. 2012 Jan;3(1):20-3. doi: 10.4103/0976-7800.98812.
4
Hormonal contraception--what kind, when, and for whom?激素避孕——哪种、何时、以及针对谁？
Dtsch Arztebl Int. 2011 Jul;108(28-29):495-505; quiz 506. doi: 10.3238/arztebl.2011.0495. Epub 2011 Jul 18.
本文引用的文献
1
Hormonal contraception and risk of venous thromboembolism: national follow-up study.激素避孕与静脉血栓栓塞风险：全国性随访研究
BMJ. 2009 Aug 13;339:b2890. doi: 10.1136/bmj.b2890.
2
Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.左炔诺孕酮宫内缓释系统长期使用期间的血清左炔诺孕酮水平及子宫内膜厚度
Contraception. 2009 Jul;80(1):84-9. doi: 10.1016/j.contraception.2009.01.004. Epub 2009 Feb 27.
3
Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis.左炔诺孕酮宫内节育系统与子宫内膜切除术治疗月经过多：一项系统评价与荟萃分析
Obstet Gynecol. 2009 May;113(5):1104-1116. doi: 10.1097/AOG.0b013e3181a1d3ce.
4
Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.一类新型甾体激素的妇科应用：选择性孕激素受体调节剂
Gynecol Endocrinol. 2009 Feb;25(2):67-73. doi: 10.1080/09513590802531120.
5
A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system.对使用左炔诺孕酮宫内节育系统的子宫内膜异位症和盆腔疼痛女性进行的3年随访。
Eur J Obstet Gynecol Reprod Biol. 2009 Apr;143(2):128-9. doi: 10.1016/j.ejogrb.2008.12.012. Epub 2009 Jan 31.
6
Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.左炔诺孕酮宫内缓释系统治疗月经过多：对卵巢功能和子宫的影响。
Arch Gynecol Obstet. 2009 Jul;280(1):39-42. doi: 10.1007/s00404-008-0871-5. Epub 2008 Dec 10.
7
The effect of levonorgestrel intrauterine system on uterine myomas: a 1-year follow-up study.左炔诺孕酮宫内节育系统对子宫肌瘤的影响：一项为期1年的随访研究。
J Minim Invasive Gynecol. 2008 Nov-Dec;15(6):735-8. doi: 10.1016/j.jmig.2008.08.011.
8
Advances in treatment options of endometriosis.子宫内膜异位症治疗选择的进展
Gynecol Obstet Invest. 2009;67(2):81-91. doi: 10.1159/000163071. Epub 2008 Oct 16.
9
Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only.前瞻性D评分分类后子宫内膜增生的治疗结果：一项比较左炔诺孕酮宫内节育器和口服孕激素与单纯观察效果的随访研究
Gynecol Oncol. 2008 Oct;111(1):68-73. doi: 10.1016/j.ygyno.2008.06.014. Epub 2008 Aug 6.
10
Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.左炔诺孕酮宫内节育系统对服用他莫昔芬的乳腺癌患者血清脂质及子宫内膜的长期影响。
Climacteric. 2008 Jun;11(3):252-7. doi: 10.1080/13697130802163168.
Zotero 插件